SABS
SAB Biotherapeutics Inc
3.00$
-2.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +214.0% | +43.5% | -37.3% | +64.9% | -47.3% | +291.0% | |
| – | +270.9% | +45.7% | -56.0% | +166.6% | -59.6% | +324.7% | |
| – | +98.7% | +163.3% | -54.7% | +275.9% | -84.3% | +18.0% | |
| – | +98.7% | +163.3% | -54.7% | +275.9% | -63.3% | +365.3% | |
| – | +629.7% | -61.1% | -30.6% | -100.0% | – | +1,622.8% | |
| – | +153.4% | +40.1% | -24.9% | – | – | – | |
| – | -13.7% | +143.0% | -53.4% | +34.2% | -31.6% | +17.0% | |
| – | +139.5% | +139.2% | -43.3% | -27.9% | -26.2% | +33.9% | |
| – | -14.8% | +87.0% | -55.0% | +32.7% | -56.2% | +17.2% | |
| – | +240.1% | -39.6% | -17.5% | -74.3% | +79.2% | +85.6% | |
| – | +221.9% | – | – | – | – | – | |
| – | – | -1.2% | -19.4% | +84.5% | -54.7% | +483.4% | |
| – | – | – | – | – | – | – | |
| – | -37.9% | +1.2% | +59.2% | +26.9% | +67.8% | +562.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.